📰 Market Commitment News
Page 3 - Market Commitment News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Market Commitment. Real-time updates on events, politics, business and more.
August 26, 2022
Both Moderna and Pfizer/ BioNTech used the novel technology of using mRNA to deliver genetic information into a human body to develop vaccines against COVID-19... 26.08.2022, Sputnik International
August 26, 2022
Moderna on Friday filed patent infringement lawsuits against Pfizer and BioNTech "for infringing patents ce...
August 26, 2022
Moderna is suing Pfizer and BioNTech, alleging the companies copied its technology used to create their COVID-19 vaccine. The lawsuits were filed in Massachusetts and Germany.
August 26, 2022
NEW YORK CITY (dpa-AFX) - Moderna Inc. (MRNA) said on Friday that it is filing lawsuits against Pfizer Inc. (PFE) and BioNTech SE (BNTX), alleging that their Covid-19 vaccine Comirnaty, infringes
August 26, 2022
Moderna on Friday filed patent infringement lawsuits against Pfizer and BioNTech "for infringing patents central to (its) mRNA technology platform," the company said in a news release Friday.
August 26, 2022
Moderna on Friday filed patent infringement lawsuits against Pfizer and BioNTech "for infringing patents central to (its) mRNA technology platform," the company said in a news release Friday.
August 26, 2022
Moderna on Friday filed patent infringement lawsuits against Pfizer and BioNTech "for infringing patents central to (its) mRNA technology platform," the company said in a news release Friday.
August 26, 2022
Moderna said in the release that it is not aiming to remove Pfizers vaccine from the market or prevent future sales of its vaccine.
August 26, 2022
Moderna on Friday filed patent infringement lawsuits against Pfizer and BioNTech "for infringing patents central to (its) mRNA technology platform," the company said in a news release Friday.
August 3, 2022
COVID-19 vaccine coverage in low- and middle-income countries is increasing at a steady pace, but remains lower than higher-income nations. VaccinesWork spoke to Ted Chaiban, Head of the COVID-19 Vaccine Delivery Partnership, about how we can ensure nobody is left behind in the vaccine race.